Medtronic (NYSE:MDT) has had a rough three months with its share price down 6.5%. To decide if this trend could continue, we decided to look at its weak fundamentals as they shape the long-term market ...

Shares of Medtronic are benefiting from an improved earnings growth outlook. The company is capturing strong demand for its new lineup of high-tech medical devices. The stock trades at just 16 times ...

Medtronic is separating out its lower-margin diabetes care segment. It's also pouncing on a massive opportunity in robotic-assisted surgery. The healthcare leader has a terrific dividend-growth track ...